Banco Santander S.A. Increases Stock Holdings in Thermo Fisher Scientific Inc. (NYSE:TMO)

Key Points

• Banco Santander S.A. increased its stake in Thermo Fisher Scientific Inc. by 14.0%, owning a total of 87,286 shares worth approximately $43.43 million.
• Thermo Fisher Scientific reported quarterly earnings of $5.36 per share, surpassing analyst estimates of $5.22, along with a revenue of $10.86 billion.
• The company declared a dividend of $0.43 per share, with a dividend yield of 0.4%, to be paid on October 15th.

Banco Santander S.A. lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 14.0% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 87,286 shares of the medical research company's stock after acquiring an additional 10,714 shares during the quarter. Banco Santander S.A.'s holdings in Thermo Fisher Scientific were worth $43,434,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bernard Wealth Management Corp. purchased a new stake in Thermo Fisher Scientific in the fourth quarter worth $25,000. Ameriflex Group Inc. purchased a new stake in Thermo Fisher Scientific in the fourth quarter worth $30,000. IMA Advisory Services Inc. purchased a new stake in Thermo Fisher Scientific in the first quarter worth $35,000. Navigoe LLC purchased a new stake in Thermo Fisher Scientific in the fourth quarter worth $37,000. Finally, Smallwood Wealth Investment Management LLC purchased a new stake in Thermo Fisher Scientific in the first quarter worth $37,000. Institutional investors own 89.23% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on TMO shares. Robert W. Baird increased their target price on Thermo Fisher Scientific from $553.00 to $567.00 and gave the stock an "outperform" rating in a research note on Thursday, July 24th. Argus cut their target price on Thermo Fisher Scientific from $620.00 to $470.00 and set a "buy" rating on the stock in a research note on Tuesday, April 29th. Royal Bank Of Canada dropped their price objective on Thermo Fisher Scientific from $651.00 to $637.00 and set an "outperform" rating on the stock in a research report on Thursday, April 24th. The Goldman Sachs Group set a $610.00 price objective on Thermo Fisher Scientific and gave the company a "buy" rating in a research report on Wednesday, April 23rd. Finally, Evercore ISI dropped their price objective on Thermo Fisher Scientific from $500.00 to $480.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 8th. Six research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $593.00.

Thermo Fisher Scientific Stock Performance

Shares of NYSE TMO traded down $4.94 during trading on Friday, hitting $462.74. The company had a trading volume of 2,756,840 shares, compared to its average volume of 3,361,249. The stock has a 50 day simple moving average of $420.88 and a 200 day simple moving average of $466.41. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.50 and a current ratio of 1.93. Thermo Fisher Scientific Inc. has a 12 month low of $385.46 and a 12 month high of $627.88. The firm has a market capitalization of $174.68 billion, a P/E ratio of 26.76, a price-to-earnings-growth ratio of 2.47 and a beta of 0.74.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last issued its earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.22 by $0.14. The company had revenue of $10.86 billion for the quarter, compared to the consensus estimate of $10.68 billion. Thermo Fisher Scientific had a return on equity of 16.82% and a net margin of 15.24%. The firm's quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter last year, the company earned $5.37 EPS. As a group, analysts anticipate that Thermo Fisher Scientific Inc. will post 23.28 earnings per share for the current year.

Thermo Fisher Scientific Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Monday, September 15th will be paid a dividend of $0.43 per share. This represents a $1.72 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Monday, September 15th. Thermo Fisher Scientific's dividend payout ratio (DPR) is 9.95%.

Insider Transactions at Thermo Fisher Scientific

In other Thermo Fisher Scientific news, EVP Gianluca Pettiti sold 400 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $479.98, for a total transaction of $191,992.00. Following the completion of the transaction, the executive vice president owned 22,367 shares in the company, valued at $10,735,712.66. This trade represents a 1.76% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.